Mutational fitness landscape of human influenza H3N2 neuraminidase

Mutational fitness landscape of human influenza H3N2 neuraminidase

Show other versions (1)

Bibliographic Details
Main Authors:	Ruipeng Lei, Andrea Hernandez Garcia, Timothy J.C. Tan, Qi Wen Teo, Yiquan Wang, Xiwen Zhang, Shitong Luo, Satish K. Nair, Jian Peng, Nicholas C. Wu
Format:	Article
Language:	English
Published:	Elsevier 2023-10-01
Series:	Cell Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2211124723013682

Similar Items

Mutational fitness landscape of human influenza H3N2 neuraminidase
by: Ruipeng Lei, et al.
Published: (2023-01-01)

Prevalence and mechanisms of evolutionary contingency in human influenza H3N2 neuraminidase
by: Ruipeng Lei, et al.
Published: (2022-10-01)

Antigenic evolution of human influenza H3N2 neuraminidase is constrained by charge balancing
by: Yiquan Wang, et al.
Published: (2021-12-01)

Neuraminidase inhibitors for influenza complications.
by: Del Mar, C, et al.
Published: (2014)

Stringent and complex sequence constraints of an IGHV1-69 broadly neutralizing antibody to influenza HA stem
by: Qi Wen Teo, et al.
Published: (2023-11-01)

Fate of Neuraminidases of Influenza A Viruses
by: Yan Shaomin, et al.
Published: (2020-01-01)

Deep mutational scanning of influenza A virus neuraminidase facilitates the identification of drug resistance mutations in vivo
by: Sihan Wang, et al.
Published: (2023-10-01)

Bacterial neuraminidase rescues influenza virus replication from inhibition by a neuraminidase inhibitor.
by: Tomoko Nishikawa, et al.
Published: (2012-01-01)

Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses
by: Butler, Jeff, et al.
Published: (2014)

Neuraminidase inhibitors for preventing and treating influenza in children.
by: Matheson, N, et al.
Published: (2003)

Neuraminidase inhibitors for preventing and treating influenza in children
by: Wang, K, et al.
Published: (2012)

Neuraminidase inhibitors for preventing and treating influenza in children.
by: Wang, K, et al.
Published: (2012)

Pharmacokinetic Properties of Anti-Influenza Neuraminidase Inhibitors.
by: Chairat, K, et al.
Published: (2012)

Anti-neuraminidase immunity in the combat against influenza
by: Xiaojian Zhang, et al.
Published: (2024-12-01)

Neuraminidase inhibitors for preventing and treating influenza in children.
by: Matheson, N, et al.
Published: (2007)

Pharmacokinetic properties of anti-influenza neuraminidase inhibitors.
by: Chairat, K, et al.
Published: (2013)

Exploring the chemical space of influenza neuraminidase inhibitors
by: Nuttapat Anuwongcharoen, et al.
Published: (2016-04-01)

Study of Antibodies to Influenza Neuraminidase N2
by: Yulia Desheva, et al.
Published: (2022-04-01)

Etiotropic therapy and chemoprophylaxis of influenza with neuraminidase inhibitors
by: T. G. Zubkova, et al.
Published: (2020-01-01)

THE STUDY OF INFLUENZA VIRUS NEURAMINIDASE HYDRATION DEGREE
by: N. S. Grebenkina, et al.
Published: (2018-01-01)

Systematic review of influenza resistance to the neuraminidase inhibitors
by: Boivin Guy, et al.
Published: (2011-05-01)

Inherent Serum Inhibition of Influenza Virus Neuraminidases
by: Amanda L. Skarlupka, et al.
Published: (2021-08-01)

Mutation of the second sialic acid-binding site of influenza A virus neuraminidase drives compensatory mutations in hemagglutinin.
by: Wenjuan Du, et al.
Published: (2020-08-01)

Influenza B Viruses with Mutation in the Neuraminidase Active Site, North Carolina, USA, 2010–11
by: Katrina Sleeman, et al.
Published: (2011-11-01)

Influenza A virus hemagglutinin mutations associated with use of neuraminidase inhibitors correlate with decreased inhibition by anti-influenza antibodies
by: Natalia A. Ilyushina, et al.
Published: (2019-11-01)

Neuraminidase Inhibitors in Influenza Treatment and Prevention–Is It Time to Call It a Day?
by: César Parra-Rojas, et al.
Published: (2018-08-01)

Antibody Neutralization of an Influenza Virus that Uses Neuraminidase for Receptor Binding
by: Lauren E. Gentles, et al.
Published: (2020-05-01)

Influenza A Virus: Phylogeny of Neuraminidase Primers and Amplification of Polymerase Basic Protein 2 and Neuraminidase Genes
by: MARIA OMEGA, et al.
Published: (2010-08-01)

Reduced Susceptibility to Neuraminidase Inhibitors in Influenza B Isolate, Canada
by: Yacine Abed, et al.
Published: (2019-04-01)

Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children.
by: Jefferson, T, et al.
Published: (2014)

Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children
by: Jefferson, T, et al.
Published: (2014)

Economics of Neuraminidase Inhibitor Stockpiling for Pandemic Influenza, Singapore
by: Vernon J. Lee, et al.
Published: (2006-01-01)

Influenza treatment and prophylaxis with neuraminidase inhibitors: a review
by: Kamali A, et al.
Published: (2013-11-01)

Influenza Neuraminidase Characteristics and Potential as a Vaccine Target
by: Sarah Creytens, et al.
Published: (2021-11-01)

Kinetic, Thermodynamic, and Structural Analysis of Drug Resistance Mutations in Neuraminidase from the 2009 Pandemic Influenza Virus
by: Jana Pokorná, et al.
Published: (2018-06-01)

A computational-experimental approach identifies mutations that enhance surface expression of an oseltamivir-resistant influenza neuraminidase.
by: Jesse D Bloom, et al.
Published: (2011-01-01)

Phenotypic effects of mutations observed in the neuraminidase of human origin H5N1 influenza A viruses.
by: David Scheibner, et al.
Published: (2023-02-01)

Neuraminidase inhibitor susceptibility and neuraminidase enzyme kinetics of human influenza A and B viruses circulating in Thailand in 2010-2015.
by: Nipaporn Tewawong, et al.
Published: (2018-01-01)

In Vitro Properties and Virulence of Contemporary Recombinant Influenza B Viruses Harboring Mutations of Cross-Resistance to Neuraminidase Inhibitors
by: Clément Fage, et al.
Published: (2018-12-01)

A Computational Assay that Explores the Hemagglutinin/Neuraminidase Functional Balance Reveals the Neuraminidase Secondary Site as a Novel Anti-Influenza Target
by: Rommie E. Amaro, et al.
Published: (2018-11-01)